Survival Benefit of Experience of Liver Resection for Advanced Recurrent Hepatocellular Carcinoma Treated with Sorafenib: A Propensity Score Matching Analysis

Several studies have shown that liver resection (LR) confers better survival outcomes in intermediate- and advanced-stage hepatocellular carcinoma (HCC) patients. However, the postoperative recurrence rate is high, and little is known about the survival benefits of LR for recurrent HCC patients who...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Kuan-Chun Hsueh, Cheng-Chun Lee, Pi-Teh Huang, Chih-Yu Liang, Shun-Fa Yang
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	MDPI AG 2023-03-01
Schriftenreihe:	Current Oncology
Schlagworte:	advanced hepatocellular carcinoma surgical resection postoperative recurrence sorafenib survival outcome
Online-Zugang:	https://www.mdpi.com/1718-7729/30/3/243
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!